Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovering immunoreceptor coupling and organization motifs. | Front Immunol | 2023 | 37731510 | PubTator, text mining | PubMed |
| Identification of protein biomarkers associated with congenital diaphragmatic hernia in human amniotic fluid. | Sci Rep | 2023 | 37726509 | PubTator, text mining | PubMed |
| Temporal dynamics of microglia-astrocyte interaction in neuroprotective glial scar formation after intracerebral hemorrhage. | J Pharm Anal | 2023 | 37719195 | PubTator, text mining | PubMed |
| Novel quinazoline-1,2,3-triazole hybrids with anticancer and MET kinase targeting properties. | Sci Rep | 2023 | 37673888 | PubTator, text mining | PubMed |
| HNRNPA2B1 is a potential biomarker of breast cancer related to prognosis and immune infiltration. | Aging (Albany NY) | 2023 | 37671941 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison. | Virol J | 2023 | 37658454 | PubTator, text mining | PubMed |
| Towards understandings of serine/arginine-rich splicing factors. | Acta Pharm Sin B | 2023 | 37655328 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of thiazole/thiadiazole carboxamide scaffold-based derivatives as potential c-Met kinase inhibitors for cancer treatment. | J Enzyme Inhib Med Chem | 2023 | 37642355 | PubTator, text mining | PubMed |
| Evolutionary Action-Machine Learning Model Identifies Candidate Genes Associated With Early-Onset Coronary Artery Disease. | J Am Heart Assoc | 2023 | 37642027 | PubTator, text mining | PubMed |
| Plexins as Regulators of Cancer Cell Proliferation, Migration, and Invasivity. | Cancers (Basel) | 2023 | 37627074 | PubTator, text mining | PubMed |
| The Role of Osteopontin in Respiratory Health and Disease. | J Pers Med | 2023 | 37623509 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. | Nat Commun | 2023 | 37596273 | PubTator, text mining | PubMed |
| Advances in the Application of Apoptotic Proteins and Alternative Splicing in Tumor Therapy: A Narrative Review. | Iran J Public Health | 2023 | 37593500 | PubTator, text mining | PubMed |
| Recent advances in non-small cell lung cancer targeted therapy; an update review. | Cancer Cell Int | 2023 | 37568193 | PubTator, text mining | PubMed |
| Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects. | World J Gastrointest Oncol | 2023 | 37546556 | PubTator, text mining | PubMed |
| Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders. | Front Immunol | 2023 | 37545504 | PubTator, text mining | PubMed |
| The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers. | Viruses | 2023 | 37515259 | PubTator, text mining | PubMed |
| The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies. | Molecules | 2023 | 37513232 | PubTator, text mining | PubMed |
| Time-Course of Transcriptomic Change in the Lungs of F344 Rats Repeatedly Exposed to a Multiwalled Carbon Nanotube in a 2-Year Test. | Nanomaterials (Basel) | 2023 | 37513116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=6